Stengone Carmine N. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Stengone Carmine N.（CIK 1861519）在 1 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-09-08）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-08 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 2,500 | $41,142 |
| 2026-09-08 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 2,500 | $2,525 |
| 2026-08-03 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 2,500 | $40,029 |
| 2026-08-03 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 2,500 | $2,525 |
| 2026-07-08 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 2,500 | $2,525 |
| 2026-07-08 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 2,500 | $40,000 |
| 2026-07-01 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 7,500 | $7,575 |
| 2026-07-01 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 2,500 | $3,150 |
| 2026-07-01 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 10,000 | $160,080 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 4,400 | $5,544 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 4,400 | $70,488 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 2,700 | $3,402 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 2,700 | $43,254 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 买入 | 400 | $504 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | CEO and President | 卖出 | 400 | $6,400 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08